Doris Duke Charitable Foundation
68
12
16
42
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
10.3%
7 terminated/withdrawn out of 68 trials
85.7%
-0.8% vs industry average
18%
12 trials in Phase 3/4
31%
13 of 42 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (68)
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
Role: collaborator
Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease
Role: collaborator
Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders
Role: collaborator
Bedside Improvement of Resuscitation Through mHealth Feedback (BIRTH Study)
Role: collaborator
Cleaner Air for Lower Cardiometabolic Risk
Role: collaborator
PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology
Role: collaborator
Dupilumab De-escalation in Pediatric Atopic Dermatitis
Role: collaborator
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Role: collaborator
Neuromodulation Therapy for Task-Specific Dystonia
Role: collaborator
Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease
Role: collaborator
The COMBAT HBV Feasibility Trial
Role: collaborator
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy
Role: collaborator
CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
Role: collaborator
Registry for Systemic Eczema Treatments
Role: collaborator
Transforming Research and Clinical Knowledge in Geriatric Traumatic Brain Injury (TRACK-GERI)
Role: collaborator
Teachers Leading the Front Lines - Adolescent
Role: collaborator
Improving the Mental Health of Home Health Aides
Role: collaborator
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
Role: collaborator
Vancomycin Study in Multiple Sclerosis (MS)
Role: collaborator
Sickle Cell Disease (SCD) Bone Pain Study
Role: collaborator